This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Glaxosmithkline Intellectual Property Development Limited, Glaxosmithkline Intellectual Property (No.2) Limited, Glaxosmithkline LLC. Active years: 2017-2021.
Company Filing History:
2 out of 242 
1 out of 95 
1 out of 358 
Years Active: 2017-2021
Title: Rino Antonio Bit: Innovator in Bromodomain Inhibitors
Introduction
Rino Antonio Bit is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target bromodomain proteins. With a total of 4 patents to his name, his work has implications for treating various diseases.
Latest Patents
Rino Antonio Bit's latest patents include innovative benzimidazole derivatives as bromodomain inhibitors. These compounds, defined by specific formulas, have been found to inhibit the binding of the BET family of bromodomain proteins to acetylated lysine residues. This inhibition may have therapeutic applications, particularly in the treatment of autoimmune and inflammatory diseases, such as rheumatoid arthritis, as well as certain cancers.
Career Highlights
Throughout his career, Rino Antonio Bit has worked with prominent organizations, including GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Intellectual Property (No. 2) Limited. His experience in these companies has allowed him to advance his research and contribute to the development of groundbreaking therapies.
Collaborations
Rino Antonio Bit has collaborated with esteemed colleagues, including John Alexander Brown and Dominique Amans. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.
Conclusion
Rino Antonio Bit's contributions to the field of medicinal chemistry, particularly through his patents on bromodomain inhibitors, highlight his role as an influential inventor. His work continues to pave the way for potential therapies that could significantly impact the treatment of various diseases.